KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Cash (2016 - 2025)

Historic Change in Cash for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $9.0 million.

  • Medtronic's Change in Cash fell 8915.66% to $9.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$112.0 million, marking a year-over-year decrease of 23493.98%. This contributed to the annual value of $934.0 million for FY2025, which is 46061.78% up from last year.
  • Medtronic's Change in Cash amounted to $9.0 million in Q4 2025, which was down 8915.66% from -$945.0 million recorded in Q3 2025.
  • Medtronic's Change in Cash's 5-year high stood at $2.7 billion during Q4 2022, with a 5-year trough of -$3.0 billion in Q2 2023.
  • Its 5-year average for Change in Cash is -$256.9 million, with a median of -$129.0 million in 2021.
  • Per our database at Business Quant, Medtronic's Change in Cash soared by 268461.54% in 2022 and then plummeted by 360000.0% in 2025.
  • Quarter analysis of 5 years shows Medtronic's Change in Cash stood at -$104.0 million in 2021, then soared by 2684.62% to $2.7 billion in 2022, then plummeted by 101.04% to -$28.0 million in 2023, then surged by 396.43% to $83.0 million in 2024, then tumbled by 89.16% to $9.0 million in 2025.
  • Its Change in Cash was $9.0 million in Q4 2025, compared to -$945.0 million in Q3 2025 and $978.0 million in Q2 2025.